Chemoinformaics analysis of LAURIC-ACID-ETHYL-ESTER
| Molecular Weight | 228.376 | nRot | 11 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 1 |
| Exact Molecular Weight | 228.209 | nRing | 0 |
| Solubility: LogS | -5.577 | nHRing | 0 |
| Solubility: LogP | 5.541 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 43.6542 |
| nHD | 0 | BPOL | 30.6938 |
| QED | 0.385 |
| Synth | 1.648 |
| Natural Product Likeliness | 0.152 |
| NR-PPAR-gamma | 0.107 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.47 |
| Pgp-sub | 0.002 |
| HIA | 0.001 |
| CACO-2 | -4.575 |
| MDCK | 0.0000222 |
| BBB | 0.431 |
| PPB | 0.969025 |
| VDSS | 1.1 |
| FU | 0.0218027 |
| CYP1A2-inh | 0.946 |
| CYP1A2-sub | 0.218 |
| CYP2c19-inh | 0.686 |
| CYP2c19-sub | 0.108 |
| CYP2c9-inh | 0.516 |
| CYP2c9-sub | 0.895 |
| CYP2d6-inh | 0.095 |
| CYP2d6-sub | 0.07 |
| CYP3a4-inh | 0.357 |
| CYP3a4-sub | 0.111 |
| CL | 5.867 |
| T12 | 0.486 |
| hERG | 0.157 |
| Ames | 0.006 |
| ROA | 0.05 |
| SkinSen | 0.942 |
| Carcinogencity | 0.106 |
| EI | 0.979 |
| Respiratory | 0.787 |
| NR-Aromatase | 0.034 |
| Antiviral | Yes |
| Prediction | 0.776475 |